Sanders Slams Biden for Rejecting Request to Lower Price of $190k Cancer Drug
The administration rejected a request to lower the price of prostate cancer drug Xtandi this week.Sen. Bernie Sanders speaks to Stephane Bancel, CEO and director of Moderna, Inc., during the Senate Health, Education, Labor, and Pensions Committee on the price of Covid vaccines, on Capitol Hill in Washington, D.C., on March 22, 2023.STEFANI REYNOLDS / AFP via Getty Images Sen. Bernie Sanders (I-Vermont) has condemned the Biden administration's decision this week to reject a request to lower the price of an extremely expensive prostate cancer drug that can help extend the lives of patients for months or years.